Role of MAPK and PKA in regulation of rbOCT2-mediated renal organic cation transport.
The effects of protein kinases MAPK and PKA on the regulation of organic cation transporter 2 (OCT2) were investigated both in a heterologous cell system [Chinese hamster ovary (CHO-K1) cells stably transfected with rabbit (rb)OCT2] and in native intact rabbit renal proximal S2 segments. Inhibition of MEK (by U-0126) or PKA (by H-89) reduced transport activity of rbOCT2 in CHO-K1 cells. The inhibitory effect of U-0126 combined with H-89 produced no additive effect, indicating that the action of PKA and MAPK in the regulation of rbOCT2 is in a common pathway. Activation of PKA by forskolin stimulated rbOCT2 activity, and this stimulatory effect was eliminated by H-89, indicating that the stimulation required PKA activation. In S2 segments of rabbit renal proximal tubules, activation of MAPK (by EGF) and PKA (by forskolin) stimulated activity of rbOCT2, and this activation was abolished by U-0126 and H-89, respectively. This is the first study to show that MAPK and PKA are involved, apparently in a common pathway, in the regulation of OCT2 activity in both a heterologous cell system and intact renal proximal tubules.
Soodvilai
Sunhapas
S
Ubon Rajathanee University, Thailand.
Chatsudthipong
Atip
A
Chatsudthipong
Varanuj
V
D000465:Algorithms; D000818:Animals; D001693:Biological Transport, Active / Q000502:physiology; D002070:Butadienes / Q000494:pharmacology; D016466:CHO Cells; D002412:Cations / Q000378:metabolism*; D005576:Colforsin / Q000494:pharmacology; D006224:Cricetinae; D003412:Cricetulus; D017868:Cyclic AMP-Dependent Protein Kinases / Q000037:antagonists & inhibitors / Q000502:physiology*; D020536:Enzyme Activators / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004815:Epidermal Growth Factor / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism*; D007687:Kidney Tubules, Proximal / Q000201:enzymology / Q000378:metabolism; D007700:Kinetics; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000502:physiology*; D009570:Nitriles / Q000494:pharmacology; D027701:Organic Cation Transport Proteins / Q000037:antagonists & inhibitors / Q000502:physiology*; D011817:Rabbits; D011994:Recombinant Proteins / Q000378:metabolism; D013449:Sulfonamides / Q000494:pharmacology; D013757:Tetraethylammonium Compounds / Q000378:metabolism
D002070:Butadienes; D002412:Cations; D020536:Enzyme Activators; D004791:Enzyme Inhibitors; D007546:Isoquinolines; D009570:Nitriles; D027701:Organic Cation Transport Proteins; D011994:Recombinant Proteins; D013449:Sulfonamides; D013757:Tetraethylammonium Compounds; C113580:U 0126; D005576:Colforsin; D004815:Epidermal Growth Factor; D017868:Cyclic AMP-Dependent Protein Kinases; D020928:Mitogen-Activated Protein Kinases; C063509:N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide